Carnegie acted as sole financial adviser in the fully guaranteed SEK 246 million rights issue in Hansa Medical. Hansa Medical is a biopharmaceutical company focused on novel immunomodulatory enzymes. April 2015.
Healthcare
Rights issue in Hansa Medical AB (SE) — SEK 246 million
April 2015